Tempest Therapeutics, Inc. (NASDAQ:TPST – Get Free Report) traded down 4.9% on Thursday . The stock traded as low as $3.41 and last traded at $3.50. 488,163 shares changed hands during trading, a decline of 31% from the average session volume of 710,658 shares. The stock had previously closed at $3.68. Analyst Ratings Changes Separately, […]
In an unprecedented leap in oncology therapeutics, Tempest Therapeutics presents compelling data at ASCO 2024, underscoring its commitment to revolutionize liver cancer treatment. The company s novel.
Tempest Therapeutics, Inc. (NASDAQ:TPST) Sees Significant Growth in Short Interest theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Tempest Therapeutics, Inc. (NASDAQ:TPST) Sees Significant Growth in Short Interest themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.